Parole chiave di "Long-term exposure to the new nicotinic agonist 1,2-bis-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuorblastoma cells."

Label

• Parole chiave di "Long-term exposure to the new nicotinic agonist 1,2-bis-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuorblastoma cells." (literal)
• Keywords of "Long-term exposure to the new nicotinic agonist 1,2-bis-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuorblastoma cells." (literal)

Insieme di parole chiave di

• Long-term exposure to the new nicotinic agonist 1,2-bis-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuorblastoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Ha membro

• BETA 2 (Parola chiave)
• CYTISINE DERIVATIVES (Parola chiave)
• ACETYLCHOLINE-RECEPTORS (Parola chiave)
• CHROMAFFIN CELLS (Parola chiave)
• BINDING-SITES (Parola chiave)

Incoming links:

Insieme di parole chiave

• Long-term exposure to the new nicotinic agonist 1,2-bis-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuorblastoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Membro di

• ACETYLCHOLINE-RECEPTORS (Parola chiave)
• CHROMAFFIN CELLS (Parola chiave)
• BETA 2 (Parola chiave)
• CYTISINE DERIVATIVES (Parola chiave)
• BINDING-SITES (Parola chiave)